. (PCYC)
$261.25 - (-)
Market Cap: -
As of 09/16/16 12:00 AM EDT. Market closed.
. (PCYC)
$261.25
- (-)
Market Cap: -
As of 09/16/16 12:00 AM EDT. Market closed.
Add to Portfolio
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$261.25
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$261.25
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| HALVORSON ERIC H | Director | May 26, 2015 | Option Exercise | $261.25 | 1,000 | 261,250 | 0 | May 28, 2015, 07:25 PM |
| Booth Robert F. | Director | May 26, 2015 | Option Exercise | $261.25 | 10,000 | 2,612,500 | 0 | May 28, 2015, 07:01 PM |
| van den Broek Richard | Director | May 26, 2015 | Option Exercise | $261.25 | 29,610 | 7,735,613 | 0 | May 28, 2015, 06:57 PM |
| Smith David Duane | Director | May 26, 2015 | Option Exercise | $261.25 | 3,000 | 783,750 | 0 | May 28, 2015, 06:51 PM |
| Tan Heow | Chief Quality&Tech Operations | May 26, 2015 | Option Exercise | $261.25 | 11,721 | 3,062,111 | 0 | May 28, 2015, 06:39 PM |
| Tomasello Shawn | Chief Commercial Officer | May 26, 2015 | Option Exercise | $261.25 | 50,000 | 13,062,500 | 7,302 | May 28, 2015, 06:37 PM |
| Tomasello Shawn | Chief Commercial Officer | May 26, 2015 | Option Exercise | $261.25 | 7,302 | 1,907,648 | 0 | May 28, 2015, 06:37 PM |
| Tomasello Shawn | Chief Commercial Officer | May 26, 2015 | Option Exercise | $261.25 | 32 | 8,360 | 0 | May 28, 2015, 06:37 PM |
| Tomasello Shawn | Chief Commercial Officer | May 26, 2015 | Option Exercise | $261.25 | 61 | 15,936 | 0 | May 28, 2015, 06:37 PM |
| Tomasello Shawn | Chief Commercial Officer | May 26, 2015 | Option Exercise | $261.25 | 109 | 28,476 | 0 | May 28, 2015, 06:37 PM |
| Soni Manmeet Singh | Chief Financial Officer | May 26, 2015 | Option Exercise | $261.25 | 54,000 | 14,107,500 | 873 | May 28, 2015, 06:35 PM |
| Soni Manmeet Singh | Chief Financial Officer | May 26, 2015 | Option Exercise | $261.25 | 873 | 228,071 | 0 | May 28, 2015, 06:35 PM |
| Zanganeh Maky | Chief Operating Officer | May 26, 2015 | Option Exercise | $261.25 | 15,000 | 3,918,750 | 351,293 | May 28, 2015, 06:33 PM |
| Zanganeh Maky | Chief Operating Officer | May 26, 2015 | Option Exercise | $261.25 | 75,363 | 19,688,584 | 0 | May 28, 2015, 06:33 PM |
| Zanganeh Maky | Chief Operating Officer | May 26, 2015 | Option Exercise | $261.25 | 351,293 | 91,775,296 | 0 | May 28, 2015, 06:33 PM |
| Zanganeh Maky | Chief Operating Officer | May 26, 2015 | Option Exercise | $261.25 | 725 | 189,406 | 0 | May 28, 2015, 06:33 PM |
| Zanganeh Maky | Chief Operating Officer | May 26, 2015 | Option Exercise | $261.25 | 900 | 235,125 | 0 | May 28, 2015, 06:33 PM |
| DUGGAN ROBERT W | Chairman and CEO | May 26, 2015 | Option Exercise | $261.25 | 170,379 | 44,511,514 | 0 | May 28, 2015, 06:30 PM |
| DUGGAN ROBERT W | Chairman and CEO | May 26, 2015 | Option Exercise | $261.25 | 42,020 | 10,977,725 | 0 | May 28, 2015, 06:30 PM |
| DUGGAN ROBERT W | Chairman and CEO | May 26, 2015 | Option Exercise | $261.25 | 153,356 | 40,064,255 | 0 | May 28, 2015, 06:30 PM |
| DUGGAN ROBERT W | Chairman and CEO | May 26, 2015 | Option Exercise | $261.25 | 13,225,531 | 3,455,169,974 | 0 | May 28, 2015, 06:30 PM |
| Tan Heow | Chief Quality&Tech Operations | Apr 13, 2015 | Option Exercise | $27.05 | 3,696 | 99,977 | 11,462 | Apr 13, 2015, 08:38 PM |
| Tan Heow | Chief Quality&Tech Operations | Mar 17, 2015 | Option Exercise | $27.05 | 3,696 | 99,977 | 7,766 | Mar 17, 2015, 08:05 PM |
| Zanganeh Maky | Chief Operating Officer | Mar 12, 2015 | Option Exercise | $1.28 | 140,719 | 180,279 | 366,031 | Mar 16, 2015, 08:45 PM |
| Zanganeh Maky | Chief Operating Officer | Mar 11, 2015 | Option Exercise | $7.19 | 30,000 | 215,700 | 255,312 | Mar 16, 2015, 08:45 PM |
| Zanganeh Maky | Chief Operating Officer | Mar 11, 2015 | Sale | $254.12 | 30,000 | 7,623,450 | 225,312 | Mar 16, 2015, 08:45 PM |
| Soni Manmeet Singh | Chief Financial Officer | Mar 11, 2015 | Option Exercise | $75.06 | 24,098 | 1,808,849 | 82,125 | Mar 13, 2015, 06:25 PM |
| Soni Manmeet Singh | Chief Financial Officer | Mar 11, 2015 | Sale | $254.15 | 24,098 | 6,124,507 | 58,027 | Mar 13, 2015, 06:25 PM |
| Soni Manmeet Singh | Chief Financial Officer | Mar 13, 2015 | Sale | $254.91 | 3,416 | 870,756 | 57,125 | Mar 13, 2015, 06:25 PM |
| Zanganeh Maky | Chief Operating Officer | Mar 12, 2015 | Option Exercise | $1.28 | 140,719 | 180,279 | 366,031 | Mar 13, 2015, 05:54 PM |
| Zanganeh Maky | Chief Operating Officer | Mar 11, 2015 | Option Exercise | $7.19 | 30,000 | 215,700 | 255,312 | Mar 13, 2015, 05:54 PM |
| Zanganeh Maky | Chief Operating Officer | Mar 11, 2015 | Sale | $254.12 | 30,000 | 7,623,450 | 225,312 | Mar 13, 2015, 05:54 PM |
| Tan Heow | Chief Quality&Tech Operations | Mar 12, 2015 | Option Exercise | $27.05 | 1,000 | 27,050 | 5,070 | Mar 12, 2015, 07:24 PM |
| Tan Heow | Chief Quality&Tech Operations | Mar 12, 2015 | Sale | $254.51 | 1,000 | 254,506 | 4,070 | Mar 12, 2015, 07:24 PM |
| Soni Manmeet Singh | Chief Financial Officer | Mar 03, 2015 | Option Exercise | $216.76 | 2,584 | 560,121 | 58,027 | Mar 04, 2015, 07:55 PM |
| Tomasello Shawn | Chief Commercial Officer | Nov 19, 2014 | Option Exercise | $138.37 | 5,390 | 745,798 | 57,110 | Feb 27, 2015, 06:37 PM |
| Tomasello Shawn | Chief Commercial Officer | Nov 19, 2014 | Option Exercise | $138.37 | 5,390 | 745,798 | 57,110 | Nov 20, 2014, 07:17 PM |
| Fardis Maria | Chief of Oncology Ops & Allian | Nov 13, 2014 | Option Exercise | $6.84 | 3,000 | 20,520 | 6,193 | Nov 17, 2014, 04:30 PM |
| Fardis Maria | Chief of Oncology Ops & Allian | Nov 13, 2014 | Sale | $141.30 | 3,000 | 423,903 | 3,193 | Nov 17, 2014, 04:30 PM |
| Soni Manmeet Singh | Chief Financial Officer | Nov 13, 2014 | Option Exercise | $61.60 | 1,000 | 61,600 | 39,611 | Nov 17, 2014, 04:19 PM |
| Soni Manmeet Singh | Chief Financial Officer | Nov 13, 2014 | Sale | $141.44 | 1,000 | 141,442 | 38,611 | Nov 17, 2014, 04:19 PM |
| Zanganeh Maky | Chief Operating Officer | Nov 10, 2014 | Option Exercise | $2.30 | 23,000 | 52,900 | 233,312 | Nov 12, 2014, 06:07 PM |
| Zanganeh Maky | Chief Operating Officer | Nov 07, 2014 | Option Exercise | $2.30 | 1,551 | 3,567 | 211,863 | Nov 12, 2014, 06:07 PM |
| Zanganeh Maky | Chief Operating Officer | Nov 12, 2014 | Option Exercise | $7.19 | 5,931 | 42,644 | 216,243 | Nov 12, 2014, 06:07 PM |
| Zanganeh Maky | Chief Operating Officer | Nov 07, 2014 | Sale | $135.01 | 1,551 | 209,401 | 210,312 | Nov 12, 2014, 06:07 PM |
| Zanganeh Maky | Chief Operating Officer | Nov 12, 2014 | Sale | $137.96 | 5,931 | 818,218 | 210,970 | Nov 12, 2014, 06:07 PM |
| Zanganeh Maky | Chief Operating Officer | Nov 10, 2014 | Sale | $133.83 | 23,000 | 3,078,026 | 230,312 | Nov 12, 2014, 06:07 PM |
| Love Richard B | General Counsel | Nov 10, 2014 | Option Exercise | $32.38 | 1,500 | 48,570 | 1,705 | Nov 10, 2014, 06:30 PM |
| Love Richard B | General Counsel | Nov 10, 2014 | Sale | $133.87 | 1,500 | 200,805 | 205 | Nov 10, 2014, 06:30 PM |
| Fardis Maria | Chief of Oncology Ops & Allian | Nov 07, 2014 | Option Exercise | $6.84 | 5,000 | 34,200 | 8,193 | Nov 10, 2014, 06:28 PM |
| Fardis Maria | Chief of Oncology Ops & Allian | Nov 07, 2014 | Sale | $134.50 | 5,000 | 672,500 | 3,193 | Nov 10, 2014, 06:28 PM |
| Fardis Maria | Chief of Oncology Ops & Allian | Oct 31, 2014 | Option Exercise | $80.93 | 1 | 81 | 3,193 | Nov 04, 2014, 07:23 PM |
| Tan Heow | Chief Quality&Tech Operations | Oct 31, 2014 | Option Exercise | $80.93 | 1 | 81 | 4,070 | Nov 04, 2014, 07:22 PM |
| Zanganeh Maky | Chief Operating Officer | Oct 31, 2014 | Option Exercise | $80.93 | 1 | 81 | 210,312 | Nov 04, 2014, 07:18 PM |
| Soni Manmeet Singh | Chief Financial Officer | Oct 31, 2014 | Option Exercise | $80.93 | 1 | 81 | 38,611 | Nov 04, 2014, 07:16 PM |
| Love Richard B | General Counsel | Oct 31, 2014 | Option Exercise | $80.93 | 1 | 81 | 205 | Nov 04, 2014, 07:14 PM |
| Zanganeh Maky | Chief Operating Officer | Sep 03, 2014 | Option Exercise | $2.30 | 7,000 | 16,100 | 217,311 | Sep 04, 2014, 05:54 PM |
| Zanganeh Maky | Chief Operating Officer | Sep 04, 2014 | Option Exercise | $2.30 | 5,000 | 11,500 | 215,311 | Sep 04, 2014, 05:54 PM |
| Zanganeh Maky | Chief Operating Officer | Sep 04, 2014 | Sale | $122.00 | 5,000 | 610,000 | 210,311 | Sep 04, 2014, 05:54 PM |
| Zanganeh Maky | Chief Operating Officer | Sep 03, 2014 | Sale | $121.57 | 7,000 | 850,980 | 215,311 | Sep 04, 2014, 05:54 PM |
| Love Richard B | General Counsel | Aug 27, 2014 | Option Exercise | $32.38 | 1,500 | 48,570 | 1,704 | Aug 28, 2014, 09:52 PM |
| Love Richard B | General Counsel | Aug 27, 2014 | Sale | $124.00 | 1,500 | 186,000 | 204 | Aug 28, 2014, 09:52 PM |
| Tan Heow | Chief Quality&Tech Operations | Aug 21, 2014 | Option Exercise | $27.05 | 2,196 | 59,402 | 4,069 | Aug 22, 2014, 02:45 PM |
| Fardis Maria | Chief of Oncology Ops & Allian | Aug 13, 2014 | Option Exercise | $6.84 | 4,000 | 27,360 | 7,192 | Aug 15, 2014, 02:41 PM |
| Fardis Maria | Chief of Oncology Ops & Allian | Aug 13, 2014 | Sale | $121.01 | 4,000 | 484,040 | 3,192 | Aug 15, 2014, 02:41 PM |
| Tan Heow | Chief Quality&Tech Operations | Aug 13, 2014 | Option Exercise | $27.05 | 10,000 | 270,500 | 11,873 | Aug 13, 2014, 05:27 PM |
| Tan Heow | Chief Quality&Tech Operations | Aug 13, 2014 | Sale | $123.58 | 10,000 | 1,235,810 | 1,873 | Aug 13, 2014, 05:27 PM |
| McGreivy Jesse | Chief Medical Officer | Aug 07, 2014 | Option Exercise | $73.09 | 34,062 | 2,489,515 | 34,062 | Aug 07, 2014, 06:51 PM |
| McGreivy Jesse | Chief Medical Officer | Aug 07, 2014 | Sale | $120.92 | 34,062 | 4,118,607 | 0 | Aug 07, 2014, 06:51 PM |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | May 08, 2014 | Option Exercise | $25.94 | 7,710 | 199,997 | 9,653 | May 08, 2014, 06:41 PM |
| Fardis Maria | Chief of Oncology Ops & Allian | Apr 30, 2014 | Option Exercise | $80.39 | 204 | 16,400 | 3,192 | May 02, 2014, 03:48 PM |
| Love Richard B | General Counsel | Apr 30, 2014 | Option Exercise | $80.39 | 204 | 16,400 | 204 | May 01, 2014, 07:53 PM |
| Tan Heow | Chief Quality&Tech Operations | Apr 30, 2014 | Option Exercise | $80.39 | 204 | 16,400 | 1,873 | May 01, 2014, 07:52 PM |
| Zanganeh Maky | Chief Operating Officer | Apr 30, 2014 | Option Exercise | $80.39 | 204 | 16,400 | 210,311 | May 01, 2014, 07:51 PM |
| Soni Manmeet Singh | Chief Financial Officer | Apr 30, 2014 | Option Exercise | $80.39 | 204 | 16,400 | 32,610 | May 01, 2014, 07:49 PM |
| Outten Matthew | VP, Commercial Operations | Apr 30, 2014 | Option Exercise | $80.39 | 204 | 16,400 | 10,758 | May 01, 2014, 07:48 PM |
| Erdtmann Rainer M | Sr. VP, IR and Admin | Apr 30, 2014 | Option Exercise | $80.39 | 204 | 16,400 | 5,701 | May 01, 2014, 07:46 PM |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | Apr 30, 2014 | Option Exercise | $80.39 | 204 | 16,400 | 2,932 | May 01, 2014, 06:14 PM |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | Apr 30, 2014 | Option Exercise | $80.39 | 204 | 16,400 | 1,943 | May 01, 2014, 06:14 PM |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | Apr 29, 2014 | Option Exercise | $57.16 | 2,332 | 133,297 | 2,728 | May 01, 2014, 06:14 PM |
| Fardis Maria | Chief of Oncology Ops & Allian | Mar 05, 2014 | Option Exercise | $6.84 | 3,000 | 20,520 | 5,988 | Mar 07, 2014, 06:06 PM |
| Fardis Maria | Chief of Oncology Ops & Allian | Mar 05, 2014 | Sale | $140.50 | 3,000 | 421,503 | 2,988 | Mar 07, 2014, 06:06 PM |
| Hemmi Gregory | Sr. VP Chemical Operations | Mar 05, 2014 | Option Exercise | $0.86 | 15,000 | 12,900 | 53,004 | Mar 06, 2014, 06:06 PM |
| Hemmi Gregory | Sr. VP Chemical Operations | Mar 05, 2014 | Sale | $140.00 | 15,000 | 2,100,030 | 38,004 | Mar 06, 2014, 06:06 PM |
| McGreivy Jesse | Chief Medical Officer | Mar 05, 2014 | Option Exercise | $25.33 | 6,563 | 166,241 | 6,563 | Mar 06, 2014, 04:35 PM |
| McGreivy Jesse | Chief Medical Officer | Mar 05, 2014 | Sale | $139.66 | 6,563 | 916,602 | 0 | Mar 06, 2014, 04:35 PM |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | Mar 05, 2014 | Option Exercise | $25.94 | 6,253 | 162,203 | 7,992 | Mar 06, 2014, 04:33 PM |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | Mar 04, 2014 | Option Exercise | $25.94 | 13,747 | 356,597 | 15,486 | Mar 06, 2014, 04:33 PM |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | Mar 05, 2014 | Sale | $140.75 | 6,253 | 880,116 | 1,739 | Mar 06, 2014, 04:33 PM |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | Mar 04, 2014 | Sale | $137.07 | 13,747 | 1,884,329 | 1,739 | Mar 06, 2014, 04:33 PM |
| HALVORSON ERIC H | Director | Mar 04, 2014 | Option Exercise | $17.66 | 3,472 | 61,332 | 4,472 | Mar 06, 2014, 02:46 PM |
| HALVORSON ERIC H | Director | Mar 04, 2014 | Sale | $138.33 | 3,472 | 480,282 | 1,000 | Mar 06, 2014, 02:46 PM |
| Chang Betty Y | VP, Research/Biology | Mar 04, 2014 | Option Exercise | $10.24 | 17,500 | 179,238 | 21,254 | Mar 05, 2014, 08:15 PM |
| Chang Betty Y | VP, Research/Biology | Mar 04, 2014 | Sale | $137.97 | 17,500 | 2,414,492 | 3,754 | Mar 05, 2014, 08:15 PM |
| van den Broek Richard | Director | Feb 27, 2014 | Sale | $144.92 | 25,000 | 3,623,000 | 29,610 | Feb 28, 2014, 05:26 PM |
| van den Broek Richard | Director | Feb 26, 2014 | Sale | $147.13 | 25,680 | 3,778,170 | 54,610 | Feb 28, 2014, 05:26 PM |
| van den Broek Richard | Director | Feb 25, 2014 | Sale | $147.70 | 28,155 | 4,158,493 | 80,290 | Feb 28, 2014, 05:26 PM |
| Hemmi Gregory | VP Chemical Operations | Dec 30, 2013 | Option Exercise | $0.75 | 13,000 | 9,750 | 38,004 | Jan 02, 2014, 01:15 PM |
| Tan Heow | Chief Quality&Tech Operations | Dec 24, 2013 | Option Exercise | $27.05 | 1,500 | 40,575 | 1,669 | Dec 26, 2013, 06:10 PM |
| Smith David Duane | Director | Dec 20, 2013 | Option Exercise | $1.92 | 1,000 | 1,920 | 3,000 | Dec 20, 2013, 05:22 PM |
| Tan Heow | Chief Quality&Tech Operations | Dec 19, 2013 | Option Exercise | $27.05 | 5,000 | 135,250 | 5,169 | Dec 20, 2013, 02:44 PM |
| Tan Heow | Chief Quality&Tech Operations | Dec 19, 2013 | Sale | $100.87 | 5,000 | 504,351 | 2,169 | Dec 20, 2013, 02:44 PM |
| Hemmi Gregory | VP Chemical Operations | Dec 18, 2013 | Option Exercise | $0.86 | 10,000 | 8,600 | 35,004 | Dec 18, 2013, 07:30 PM |
| Hemmi Gregory | VP Chemical Operations | Dec 17, 2013 | Option Exercise | $0.86 | 10,000 | 8,600 | 35,004 | Dec 18, 2013, 07:30 PM |
| Hemmi Gregory | VP Chemical Operations | Dec 18, 2013 | Sale | $99.04 | 10,000 | 990,380 | 25,004 | Dec 18, 2013, 07:30 PM |
| Hemmi Gregory | VP Chemical Operations | Dec 17, 2013 | Sale | $102.00 | 10,000 | 1,020,000 | 25,004 | Dec 18, 2013, 07:30 PM |
| Zanganeh Maky | Chief Operating Officer | Dec 16, 2013 | Sale | $107.55 | 20,000 | 2,151,000 | 210,107 | Dec 18, 2013, 07:24 PM |
| Smith David Duane | Director | Dec 16, 2013 | Option Exercise | $54.39 | 13,000 | 707,024 | 8,500 | Dec 17, 2013, 04:16 PM |
| Erdtmann Rainer M | Sr. VP, IR and Admin | Dec 16, 2013 | Option Exercise | $0.91 | 22,835 | 20,780 | 34,332 | Dec 16, 2013, 07:13 PM |
| Erdtmann Rainer M | Sr. VP, IR and Admin | Dec 13, 2013 | Option Exercise | $0.91 | 31,165 | 28,360 | 42,662 | Dec 16, 2013, 07:13 PM |
| Erdtmann Rainer M | Sr. VP, IR and Admin | Dec 16, 2013 | Sale | $107.71 | 22,835 | 2,459,672 | 11,497 | Dec 16, 2013, 07:13 PM |
| Erdtmann Rainer M | Sr. VP, IR and Admin | Dec 13, 2013 | Sale | $107.82 | 31,165 | 3,360,117 | 11,497 | Dec 16, 2013, 07:13 PM |
| Hemmi Gregory | VP Chemical Operations | Oct 31, 2013 | Option Exercise | $10.56 | 768 | 8,108 | 25,004 | Nov 06, 2013, 02:10 PM |
| Ray Sumita | Chief Compliance Officer | Oct 31, 2013 | Option Exercise | $64.81 | 112 | 7,259 | 112 | Nov 06, 2013, 02:08 PM |
| Loury David J | Executive VP, Toxicology | Oct 31, 2013 | Option Exercise | $10.56 | 1,139 | 12,024 | 1,628 | Nov 06, 2013, 02:02 PM |
| Crum Michael | Vice President, U.S. Sales | Oct 31, 2013 | Option Exercise | $64.81 | 327 | 21,194 | 327 | Nov 06, 2013, 02:00 PM |
| Beaupre Darrin | VP, Clin. Med. & Early Dev. | Oct 31, 2013 | Option Exercise | $52.24 | 157 | 8,202 | 386 | Nov 06, 2013, 01:57 PM |
| Tan Heow | Chief Quality&Tech Operations | Oct 31, 2013 | Option Exercise | $52.24 | 169 | 8,829 | 169 | Nov 06, 2013, 01:56 PM |
| Lee Dana | VP, Clinical Drug Safety | Oct 31, 2013 | Option Exercise | $64.81 | 231 | 14,972 | 231 | Nov 06, 2013, 01:44 PM |
| Soni Manmeet Singh | Executive VP, Finance | Oct 31, 2013 | Option Exercise | $52.24 | 161 | 8,411 | 406 | Nov 06, 2013, 01:42 PM |
| Graef Thorsten | VP, Clinical Science | Oct 31, 2013 | Option Exercise | $52.24 | 143 | 7,470 | 806 | Nov 06, 2013, 01:40 PM |
| Chang Betty Y | VP, Research/Biology | Oct 31, 2013 | Option Exercise | $10.56 | 104 | 1,098 | 3,754 | Nov 06, 2013, 01:35 PM |
| Suchet Christopher | VP Information Technology | Oct 31, 2013 | Option Exercise | $64.81 | 327 | 21,194 | 327 | Nov 06, 2013, 01:34 PM |
| Faust Elizabeth | VP Medical Affairs | Oct 31, 2013 | Option Exercise | $64.81 | 327 | 21,194 | 327 | Nov 06, 2013, 01:32 PM |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | Apr 30, 2013 | Option Exercise | $52.24 | 406 | 21,210 | 406 | Nov 06, 2013, 01:29 PM |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | Oct 31, 2013 | Option Exercise | $23.07 | 81 | 1,869 | 1,739 | Nov 06, 2013, 01:29 PM |
| Shearer Scott T | VP, Global Quality | Jun 06, 2013 | Option Exercise | $30.46 | 18,750 | 571,125 | 18,750 | Jun 06, 2013, 06:46 PM |
| Shearer Scott T | VP, Global Quality | Jun 06, 2013 | Sale | $85.17 | 18,750 | 1,596,994 | 0 | Jun 06, 2013, 06:46 PM |
| Hemmi Gregory | VP Chemical Operations | May 31, 2013 | Option Exercise | $2.70 | 50,000 | 135,178 | 74,236 | May 31, 2013, 08:15 PM |
| Hemmi Gregory | VP Chemical Operations | May 31, 2013 | Sale | $91.96 | 50,000 | 4,598,115 | 24,236 | May 31, 2013, 08:15 PM |
| Tan Heow | Chief of Technical Operations | May 31, 2013 | Option Exercise | $27.05 | 5,000 | 135,250 | 5,237 | May 31, 2013, 08:06 PM |
| Tan Heow | Chief of Technical Operations | May 31, 2013 | Sale | $91.84 | 5,237 | 480,961 | 0 | May 31, 2013, 08:06 PM |
| Love Richard B | VP and General Counsel | May 31, 2013 | Option Exercise | $32.38 | 8,000 | 259,040 | 8,000 | May 31, 2013, 08:03 PM |
| Love Richard B | VP and General Counsel | May 31, 2013 | Sale | $89.00 | 8,000 | 712,000 | 0 | May 31, 2013, 08:03 PM |
| McGreivy Jesse | VP, Clinical Science | May 31, 2013 | Option Exercise | $37.86 | 14,479 | 548,103 | 14,479 | May 31, 2013, 08:02 PM |
| McGreivy Jesse | VP, Clinical Science | May 31, 2013 | Sale | $91.13 | 14,479 | 1,319,510 | 0 | May 31, 2013, 08:02 PM |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | Apr 30, 2013 | Option Exercise | $23.07 | 840 | 19,378 | 1,658 | May 01, 2013, 08:42 PM |
| Zanganeh Maky | Chief Operating Officer | Apr 30, 2013 | Option Exercise | $10.56 | 2,012 | 21,241 | 230,107 | May 01, 2013, 08:41 PM |
| Tan Heow | Chief of Technical Operations | Apr 30, 2013 | Option Exercise | $52.24 | 237 | 12,381 | 237 | May 01, 2013, 08:38 PM |
| Soni Manmeet Singh | VP, Corporate Controller | Apr 30, 2013 | Option Exercise | $52.24 | 245 | 12,799 | 245 | May 01, 2013, 08:35 PM |
| Loury David J | Chief Scientific Officer | Apr 30, 2013 | Option Exercise | $10.56 | 164 | 1,731 | 489 | May 01, 2013, 08:33 PM |
| Kunkel Lori Anne | Chief Medical Officer | Apr 30, 2013 | Option Exercise | $23.07 | 921 | 21,247 | 2,842 | May 01, 2013, 08:32 PM |
| Hemmi Gregory | VP Chemical Operations | Apr 30, 2013 | Option Exercise | $10.56 | 1,244 | 13,133 | 24,236 | May 01, 2013, 08:30 PM |
| Gayko Urte | Sr. VP, Regulatory | Apr 30, 2013 | Option Exercise | $52.24 | 406 | 21,210 | 406 | May 01, 2013, 08:25 PM |
| Fardis Maria | Chief of Oncology Ops & Allian | Apr 30, 2013 | Option Exercise | $10.56 | 2,012 | 21,241 | 2,988 | May 01, 2013, 08:22 PM |
| Erdtmann Rainer M | Sr. VP, IR and Admin | Apr 30, 2013 | Option Exercise | $10.56 | 2,012 | 21,241 | 11,497 | May 01, 2013, 08:20 PM |
| Clow Fong Wang | VP Biostatistics Data Mgmt | Apr 30, 2013 | Option Exercise | $10.56 | 2,012 | 21,241 | 4,024 | May 01, 2013, 08:18 PM |
| Buggy Joseph J | VP, Research | Apr 30, 2013 | Option Exercise | $10.56 | 2,012 | 21,241 | 8,713 | May 01, 2013, 08:16 PM |
| Buggy Joseph J | VP, Research | Feb 11, 2013 | Option Exercise | $0.86 | 12,000 | 10,320 | 18,701 | Feb 11, 2013, 07:19 PM |
| Buggy Joseph J | VP, Research | Feb 11, 2013 | Sale | $69.97 | 12,000 | 839,666 | 6,701 | Feb 11, 2013, 07:19 PM |
| Loury David J | Chief Scientific Officer | Feb 05, 2013 | Option Exercise | $2.76 | 20,000 | 55,200 | 20,325 | Feb 05, 2013, 07:08 PM |
| Loury David J | Chief Scientific Officer | Feb 05, 2013 | Sale | $70.58 | 20,000 | 1,411,510 | 325 | Feb 05, 2013, 07:08 PM |
| McGreivy Jesse | VP, Clinical Science | Jan 17, 2013 | Sale | $67.29 | 583 | 39,229 | 0 | Jan 18, 2013, 06:37 PM |
| Hemmi Gregory | VP Chemical Operations | Jan 11, 2013 | Option Exercise | $3.69 | 5,000 | 18,471 | 27,992 | Jan 11, 2013, 07:30 PM |
| Hemmi Gregory | VP Chemical Operations | Jan 11, 2013 | Sale | $67.11 | 5,000 | 335,550 | 22,992 | Jan 11, 2013, 07:30 PM |
| Loury David J | Chief Scientific Officer | Jan 09, 2013 | Sale | $35.23 | 21,062 | 742,014 | 10,856 | Jan 10, 2013, 03:15 PM |
| Fardis Maria | EVP, Operations and Alliances | Jan 08, 2013 | Sale | $65.00 | 2,500 | 162,500 | 976 | Jan 09, 2013, 07:05 PM |
| Loury David J | Chief Scientific Officer | Jan 08, 2013 | Option Exercise | $4.16 | 10,000 | 41,600 | 10,325 | Jan 08, 2013, 07:15 PM |
| Loury David J | Chief Scientific Officer | Jan 08, 2013 | Sale | $64.70 | 10,000 | 647,000 | 325 | Jan 08, 2013, 07:15 PM |
| Fardis Maria | EVP, Operations and Alliances | Jan 07, 2013 | Option Exercise | $6.84 | 3,500 | 23,940 | 6,976 | Jan 07, 2013, 08:23 PM |
| Fardis Maria | EVP, Operations and Alliances | Jan 07, 2013 | Sale | $64.20 | 3,500 | 224,700 | 3,476 | Jan 07, 2013, 08:23 PM |
| van den Broek Richard | Director | Dec 31, 2012 | Sale | $58.50 | 7,171 | 419,476 | 108,445 | Jan 02, 2013, 02:20 PM |
| van den Broek Richard | Director | Dec 28, 2012 | Sale | $57.98 | 18,354 | 1,064,125 | 108,445 | Dec 28, 2012, 04:38 PM |
| van den Broek Richard | Director | Dec 27, 2012 | Sale | $58.02 | 11,931 | 692,239 | 126,799 | Dec 28, 2012, 04:38 PM |
| Hemmi Gregory | VP Chemical Operations | Dec 26, 2012 | Option Exercise | $4.47 | 100 | 447 | 23,092 | Dec 27, 2012, 06:22 PM |
| Hemmi Gregory | VP Chemical Operations | Dec 27, 2012 | Option Exercise | $6.04 | 12,900 | 77,883 | 35,892 | Dec 27, 2012, 06:22 PM |
| Hemmi Gregory | VP Chemical Operations | Dec 27, 2012 | Sale | $59.20 | 12,900 | 763,725 | 25,617 | Dec 27, 2012, 06:22 PM |
| Hemmi Gregory | VP Chemical Operations | Dec 26, 2012 | Sale | $59.00 | 100 | 5,900 | 22,992 | Dec 27, 2012, 06:22 PM |
| Loury David J | Chief Scientific Officer | Dec 20, 2012 | Option Exercise | $4.16 | 39,469 | 164,191 | 39,794 | Dec 21, 2012, 07:09 PM |
| Loury David J | Chief Scientific Officer | Dec 20, 2012 | Sale | $61.12 | 39,469 | 2,412,274 | 325 | Dec 21, 2012, 07:09 PM |
| Erdtmann Rainer M | VP, IR Education Training | Dec 18, 2012 | Option Exercise | $0.91 | 59,558 | 54,198 | 87,043 | Dec 18, 2012, 07:05 PM |
| Erdtmann Rainer M | VP, IR Education Training | Dec 17, 2012 | Option Exercise | $0.91 | 34,442 | 31,342 | 61,927 | Dec 18, 2012, 07:05 PM |
| Erdtmann Rainer M | VP, IR Education Training | Dec 18, 2012 | Sale | $62.48 | 59,558 | 3,721,092 | 45,485 | Dec 18, 2012, 07:05 PM |
| Erdtmann Rainer M | VP, IR Education Training | Dec 17, 2012 | Sale | $62.73 | 34,442 | 2,160,698 | 27,485 | Dec 18, 2012, 07:05 PM |
| Buggy Joseph J | VP, Research | Dec 17, 2012 | Option Exercise | $0.75 | 50,000 | 37,500 | 56,701 | Dec 17, 2012, 07:10 PM |
| Buggy Joseph J | VP, Research | Dec 17, 2012 | Sale | $62.14 | 50,000 | 3,106,840 | 6,701 | Dec 17, 2012, 07:10 PM |
| Hemmi Gregory | VP Chemical Operations | Oct 31, 2012 | Option Exercise | $10.56 | 686 | 7,242 | 22,992 | Nov 02, 2012, 07:18 PM |
| Hemmi Gregory | VP Chemical Operations | May 08, 2012 | Option Exercise | $4.25 | 1,875 | 7,969 | 22,306 | Nov 02, 2012, 07:15 PM |
| Huh Christine | VP, Human Resources | Oct 31, 2012 | Option Exercise | $23.07 | 921 | 21,247 | 4,921 | Nov 02, 2012, 06:20 PM |
| McGreivy Jesse | VP, Clinical Science | Oct 31, 2012 | Option Exercise | $23.07 | 583 | 13,449 | 583 | Nov 02, 2012, 05:53 PM |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | Oct 31, 2012 | Option Exercise | $23.07 | 818 | 18,870 | 818 | Nov 02, 2012, 05:51 PM |
| Fardis Maria | EVP, Operations and Alliances | Oct 31, 2012 | Option Exercise | $10.56 | 327 | 3,452 | 3,476 | Nov 02, 2012, 05:49 PM |
| Loury David J | Chief Scientific Officer | Oct 31, 2012 | Option Exercise | $10.56 | 163 | 1,721 | 325 | Nov 02, 2012, 05:46 PM |
| Kunkel Lori Anne | Chief Medical Officer | Oct 31, 2012 | Option Exercise | $23.07 | 921 | 21,247 | 1,921 | Nov 02, 2012, 05:43 PM |
| Erdtmann Rainer M | VP, IR Education Training | Oct 31, 2012 | Option Exercise | $10.56 | 1,437 | 15,170 | 27,485 | Nov 02, 2012, 05:40 PM |
| Buggy Joseph J | VP, Research | Oct 31, 2012 | Option Exercise | $10.56 | 585 | 6,176 | 6,701 | Nov 02, 2012, 05:38 PM |
| Mehta Minesh | Director | May 17, 2012 | Option Exercise | $7.39 | 18,565 | 137,259 | 7,500 | May 21, 2012, 04:03 PM |
| Mehta Minesh | Director | May 17, 2012 | Sale | $30.00 | 18,565 | 556,950 | 0 | May 21, 2012, 04:03 PM |
| Zanganeh Maky | Chief Business Officer | Apr 30, 2012 | Option Exercise | $10.56 | 2,012 | 21,241 | 228,095 | May 02, 2012, 08:41 PM |
| Loury David J | Chief Scientific Officer | Apr 30, 2012 | Option Exercise | $10.56 | 162 | 1,710 | 29,369 | May 02, 2012, 08:39 PM |
| Hemmi Gregory | VP Chemical Operations | Apr 30, 2012 | Option Exercise | $10.56 | 455 | 4,803 | 20,431 | May 02, 2012, 08:37 PM |
| Erdtmann Rainer M | VP of Finance | Apr 30, 2012 | Option Exercise | $10.56 | 575 | 6,070 | 26,048 | May 02, 2012, 08:36 PM |
| Buggy Joseph J | VP, Research | Apr 30, 2012 | Option Exercise | $10.56 | 116 | 1,225 | 6,116 | May 02, 2012, 08:35 PM |
| Asbury Mark | VP and General Counsel | Apr 30, 2012 | Option Exercise | $10.56 | 1,427 | 15,065 | 1,427 | May 02, 2012, 08:34 PM |
| Mehta Minesh | Director | Feb 13, 2012 | Option Exercise | $2.52 | 11,971 | 30,148 | 3,750 | Feb 15, 2012, 07:36 PM |
| Mehta Minesh | Director | Feb 13, 2012 | Sale | $25.00 | 11,971 | 299,275 | 0 | Feb 15, 2012, 07:36 PM |
| Baker Biotech Capital (GP), LLC | 10% Owner | Feb 10, 2012 | Buy | $20.85 | 150,000 | 3,128,040 | 557,211 | Feb 14, 2012, 05:53 PM |
| Mehta Minesh | Director | Feb 03, 2012 | Option Exercise | $2.52 | 11,970 | 30,146 | 3,750 | Feb 07, 2012, 08:58 PM |
| Mehta Minesh | Director | Feb 03, 2012 | Sale | $20.00 | 11,970 | 239,400 | 0 | Feb 07, 2012, 08:58 PM |
| Baker Biotech Capital (GP), LLC | 10% Owner | Jan 25, 2012 | Buy | $18.53 | 21,565 | 399,626 | 365,338 | Jan 26, 2012, 06:12 PM |
| Baker Biotech Capital (GP), LLC | 10% Owner | Jan 24, 2012 | Buy | $17.95 | 22,555 | 404,958 | 343,773 | Jan 26, 2012, 06:12 PM |
| Baker Biotech Capital (GP), LLC | 10% Owner | Jan 26, 2012 | Buy | $17.93 | 41,873 | 750,902 | 407,211 | Jan 26, 2012, 06:12 PM |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Jan 24, 2012 | Buy | $17.95 | 131,311 | 2,357,591 | 8,205,104 | Jan 26, 2012, 06:12 PM |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Jan 26, 2012 | Buy | $17.93 | 243,790 | 4,371,850 | 8,574,445 | Jan 26, 2012, 06:12 PM |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Jan 25, 2012 | Buy | $18.53 | 125,551 | 2,326,615 | 8,330,655 | Jan 26, 2012, 06:12 PM |
| 14159 capital (GP), LLC | 10% Owner | Jan 26, 2012 | Buy | $17.93 | 6,304 | 113,049 | 195,858 | Jan 26, 2012, 06:09 PM |
| 14159 capital (GP), LLC | 10% Owner | Jan 25, 2012 | Buy | $18.53 | 3,246 | 60,152 | 189,554 | Jan 26, 2012, 06:09 PM |
| 14159 capital (GP), LLC | 10% Owner | Jan 24, 2012 | Buy | $17.95 | 3,395 | 60,955 | 186,308 | Jan 26, 2012, 06:09 PM |
| 14159 capital (GP), LLC | 10% Owner | Jan 20, 2012 | Buy | $16.42 | 6,536 | 107,306 | 177,940 | Jan 23, 2012, 08:40 PM |
| 14159 capital (GP), LLC | 10% Owner | Jan 19, 2012 | Buy | $16.05 | 938 | 15,055 | 171,404 | Jan 23, 2012, 08:40 PM |
| 14159 capital (GP), LLC | 10% Owner | Jan 23, 2012 | Buy | $16.87 | 4,273 | 72,097 | 182,913 | Jan 23, 2012, 08:40 PM |
| 14159 capital (GP), LLC | 10% Owner | Jan 20, 2012 | Option Exercise | $15.00 | 700 | 10,500 | 178,640 | Jan 23, 2012, 08:40 PM |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Jan 23, 2012 | Buy | $16.87 | 162,215 | 2,737,009 | 8,073,793 | Jan 23, 2012, 08:40 PM |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Jan 20, 2012 | Buy | $16.42 | 248,166 | 4,073,980 | 7,886,678 | Jan 23, 2012, 08:40 PM |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Jan 19, 2012 | Buy | $16.05 | 34,857 | 559,459 | 7,638,512 | Jan 23, 2012, 08:40 PM |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Jan 20, 2012 | Option Exercise | $15.00 | 24,900 | 373,500 | 7,911,578 | Jan 23, 2012, 08:40 PM |
| Baker Biotech Capital (GP), LLC | 10% Owner | Jan 23, 2012 | Buy | $16.87 | 28,209 | 475,963 | 321,218 | Jan 23, 2012, 08:39 PM |
| Baker Biotech Capital (GP), LLC | 10% Owner | Jan 20, 2012 | Buy | $16.42 | 43,156 | 708,524 | 288,609 | Jan 23, 2012, 08:39 PM |
| Baker Biotech Capital (GP), LLC | 10% Owner | Jan 19, 2012 | Buy | $16.05 | 6,060 | 97,264 | 245,453 | Jan 23, 2012, 08:39 PM |
| Baker Biotech Capital (GP), LLC | 10% Owner | Jan 20, 2012 | Option Exercise | $15.00 | 4,400 | 66,000 | 293,009 | Jan 23, 2012, 08:39 PM |
| Hemmi Gregory | VP Chemical Operations | Dec 30, 2011 | Option Exercise | $6.85 | 18,125 | 124,131 | 28,413 | Jan 03, 2012, 09:02 PM |
| Hemmi Gregory | VP Chemical Operations | Dec 30, 2011 | Sale | $14.91 | 18,125 | 270,310 | 19,976 | Jan 03, 2012, 09:02 PM |
| Baker Biotech Capital (GP), LLC | 10% Owner | Dec 02, 2011 | Buy | $15.42 | 14,561 | 224,467 | 239,393 | Dec 06, 2011, 06:12 PM |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Dec 02, 2011 | Buy | $15.42 | 88,197 | 1,359,615 | 7,603,655 | Dec 06, 2011, 06:09 PM |
| 14159 capital (GP), LLC | 10% Owner | Dec 02, 2011 | Buy | $15.42 | 2,360 | 36,381 | 170,466 | Dec 06, 2011, 06:08 PM |
| 14159 capital (GP), LLC | 10% Owner | Nov 28, 2011 | Buy | $13.34 | 4,052 | 54,055 | 163,723 | Nov 30, 2011, 06:20 PM |
| 14159 capital (GP), LLC | 10% Owner | Nov 29, 2011 | Buy | $14.18 | 4,383 | 62,133 | 168,106 | Nov 30, 2011, 06:20 PM |
| Baker Biotech Capital (GP), LLC | 10% Owner | Nov 30, 2011 | Buy | $14.92 | 11,164 | 166,590 | 224,832 | Nov 30, 2011, 06:19 PM |
| Baker Biotech Capital (GP), LLC | 10% Owner | Nov 29, 2011 | Buy | $14.18 | 27,871 | 395,097 | 213,668 | Nov 30, 2011, 06:19 PM |
| Baker Biotech Capital (GP), LLC | 10% Owner | Nov 28, 2011 | Buy | $13.34 | 25,764 | 343,702 | 185,797 | Nov 30, 2011, 06:19 PM |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Nov 30, 2011 | Buy | $14.92 | 65,002 | 969,966 | 7,515,458 | Nov 30, 2011, 06:19 PM |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Nov 29, 2011 | Buy | $14.18 | 162,271 | 2,300,343 | 7,450,456 | Nov 30, 2011, 06:19 PM |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Nov 28, 2011 | Buy | $13.34 | 150,007 | 2,001,154 | 7,288,185 | Nov 30, 2011, 06:19 PM |
| 14159 capital (GP), LLC | 10% Owner | Nov 23, 2011 | Buy | $12.76 | 747 | 9,532 | 159,671 | Nov 23, 2011, 05:04 PM |
| 14159 capital (GP), LLC | 10% Owner | Nov 22, 2011 | Buy | $12.78 | 3,492 | 44,640 | 158,924 | Nov 23, 2011, 05:04 PM |
| 14159 capital (GP), LLC | 10% Owner | Nov 21, 2011 | Buy | $12.07 | 2,778 | 33,526 | 155,432 | Nov 23, 2011, 05:04 PM |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Nov 23, 2011 | Buy | $12.76 | 93,194 | 1,189,165 | 7,138,178 | Nov 23, 2011, 05:04 PM |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Nov 22, 2011 | Buy | $12.78 | 79,131 | 1,011,570 | 7,044,984 | Nov 23, 2011, 05:04 PM |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Nov 21, 2011 | Buy | $12.07 | 70,173 | 846,886 | 6,965,853 | Nov 23, 2011, 05:04 PM |
| Baker Biotech Capital (GP), LLC | 10% Owner | Nov 23, 2011 | Buy | $12.76 | 3,141 | 40,079 | 160,033 | Nov 23, 2011, 05:03 PM |
| Baker Biotech Capital (GP), LLC | 10% Owner | Nov 22, 2011 | Buy | $12.78 | 2,780 | 35,538 | 156,892 | Nov 23, 2011, 05:03 PM |
| Baker Biotech Capital (GP), LLC | 10% Owner | Nov 21, 2011 | Buy | $12.07 | 1,430 | 17,258 | 154,112 | Nov 23, 2011, 05:03 PM |
| Loury David J | Chief Scientific Officer | Oct 31, 2011 | Option Exercise | $1.61 | 3,227 | 5,184 | 29,207 | Nov 02, 2011, 07:31 PM |
| Hemmi Gregory | VP Chemical Operations | Oct 31, 2011 | Option Exercise | $1.61 | 2,897 | 4,654 | 19,976 | Nov 02, 2011, 07:30 PM |
| Hedrick Eric | Vice President | Oct 31, 2011 | Option Exercise | $5.12 | 1,338 | 6,847 | 4,152 | Nov 02, 2011, 07:29 PM |
| Erdtmann Rainer M | VP of Finance | Oct 31, 2011 | Option Exercise | $1.61 | 3,227 | 5,184 | 25,473 | Nov 02, 2011, 07:28 PM |
| Baker Biotech Capital (GP), LLC | 10% Owner | Sep 30, 2011 | Buy | $11.79 | 26,163 | 308,420 | 67,682 | Oct 04, 2011, 05:01 PM |
| Baker Biotech Capital (GP), LLC | 10% Owner | Oct 03, 2011 | Buy | $11.59 | 85,000 | 985,513 | 152,682 | Oct 04, 2011, 05:01 PM |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Oct 03, 2011 | Buy | $11.59 | 81,890 | 949,454 | 6,895,680 | Oct 04, 2011, 05:01 PM |
| 14159 capital (GP), LLC | 10% Owner | Oct 03, 2011 | Buy | $11.59 | 3,110 | 36,058 | 152,654 | Oct 04, 2011, 05:00 PM |
| 14159 capital (GP), LLC | 10% Owner | Aug 22, 2011 | Buy | $9.96 | 4,426 | 44,085 | 149,544 | Aug 24, 2011, 05:12 PM |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Aug 22, 2011 | Buy | $9.96 | 287,264 | 2,861,270 | 6,813,790 | Aug 24, 2011, 05:11 PM |
| Baker Biotech Capital (GP), LLC | 10% Owner | Aug 22, 2011 | Buy | $9.96 | 39,710 | 395,528 | 41,519 | Aug 24, 2011, 05:10 PM |
| Hemmi Gregory | VP Chemical Operations | Jul 13, 2011 | Option Exercise | $0.75 | 6,000 | 4,500 | 17,079 | Jul 15, 2011, 01:24 PM |
| DUGGAN ROBERT W | Chairman & CEO | Jun 21, 2011 | Buy | $8.85 | 678,000 | 6,000,300 | 12,081,244 | Jun 24, 2011, 07:04 PM |
| Hemmi Gregory | VP Chemical Operations | Apr 29, 2011 | Option Exercise | $1.61 | 1,308 | 2,101 | 11,079 | May 03, 2011, 08:50 PM |
| Hamdy Ahmed MD | Chief Medical Officer | Apr 29, 2011 | Option Exercise | $1.61 | 5,011 | 8,050 | 11,966 | May 03, 2011, 08:49 PM |
| Hedrick Eric | Vice President | Apr 29, 2011 | Option Exercise | $5.12 | 2,814 | 14,399 | 2,814 | May 03, 2011, 08:47 PM |
| Loury David J | Chief Scientific Officer | Apr 29, 2011 | Option Exercise | $1.61 | 10,000 | 16,065 | 25,980 | May 03, 2011, 08:45 PM |
| Erdtmann Rainer M | VP of Finance | Apr 29, 2011 | Option Exercise | $1.61 | 10,000 | 16,065 | 22,246 | May 03, 2011, 08:44 PM |
| Zanganeh Maky | Chief of Staff & VP Bus. Dev. | Apr 28, 2011 | Option Exercise | $0.75 | 20,000 | 15,000 | 226,083 | May 02, 2011, 05:10 PM |
| Erdtmann Rainer M | VP of Finance | Oct 29, 2010 | Option Exercise | $1.61 | 10,000 | 16,065 | 12,246 | Nov 02, 2010, 05:23 PM |
| Loury David J | Chief Scientific Officer | Oct 29, 2010 | Option Exercise | $1.61 | 10,000 | 16,065 | 15,980 | Nov 02, 2010, 05:22 PM |
| Hamdy Ahmed MD | Chief Medical Officer | Oct 05, 2010 | Option Exercise | $0.73 | 15,000 | 10,950 | 17,010 | Oct 07, 2010, 11:30 AM |
| Hamdy Ahmed MD | Chief Medical Officer | Oct 05, 2010 | Sale | $8.20 | 15,000 | 123,000 | 2,010 | Oct 07, 2010, 11:30 AM |
| Buggy Joseph J | VP, Research | Oct 01, 2010 | Option Exercise | $1.40 | 46,630 | 65,512 | 22,687 | Oct 05, 2010, 06:14 PM |
| Buggy Joseph J | VP, Research | Oct 01, 2010 | Sale | $8.01 | 46,630 | 373,669 | 6,000 | Oct 05, 2010, 06:14 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| HALVORSON ERIC H | Director | 05/26/2015 | 261,250 |
| Booth Robert F. | Director | 05/26/2015 | 2,612,500 |
| van den Broek Richard | Director | 05/26/2015 | 7,735,613 |
| Smith David Duane | Director | 05/26/2015 | 783,750 |
| Tan Heow | Chief Quality&Tech Operations | 05/26/2015 | 3,062,111 |
| Tomasello Shawn | Chief Commercial Officer | 05/26/2015 | 13,062,500 |
| Tomasello Shawn | Chief Commercial Officer | 05/26/2015 | 1,907,648 |
| Tomasello Shawn | Chief Commercial Officer | 05/26/2015 | 8,360 |
| Tomasello Shawn | Chief Commercial Officer | 05/26/2015 | 15,936 |
| Tomasello Shawn | Chief Commercial Officer | 05/26/2015 | 28,476 |
| Soni Manmeet Singh | Chief Financial Officer | 05/26/2015 | 14,107,500 |
| Soni Manmeet Singh | Chief Financial Officer | 05/26/2015 | 228,071 |
| Zanganeh Maky | Chief Operating Officer | 05/26/2015 | 3,918,750 |
| Zanganeh Maky | Chief Operating Officer | 05/26/2015 | 19,688,584 |
| Zanganeh Maky | Chief Operating Officer | 05/26/2015 | 91,775,296 |
| Zanganeh Maky | Chief Operating Officer | 05/26/2015 | 189,406 |
| Zanganeh Maky | Chief Operating Officer | 05/26/2015 | 235,125 |
| DUGGAN ROBERT W | Chairman and CEO | 05/26/2015 | 44,511,514 |
| DUGGAN ROBERT W | Chairman and CEO | 05/26/2015 | 10,977,725 |
| DUGGAN ROBERT W | Chairman and CEO | 05/26/2015 | 40,064,255 |
| DUGGAN ROBERT W | Chairman and CEO | 05/26/2015 | 3,455,169,974 |
| Tan Heow | Chief Quality&Tech Operations | 04/13/2015 | 99,977 |
| Tan Heow | Chief Quality&Tech Operations | 03/17/2015 | 99,977 |
| Zanganeh Maky | Chief Operating Officer | 03/12/2015 | 180,279 |
| Zanganeh Maky | Chief Operating Officer | 03/11/2015 | 215,700 |
| Zanganeh Maky | Chief Operating Officer | 03/11/2015 | 7,623,450 |
| Soni Manmeet Singh | Chief Financial Officer | 03/11/2015 | 1,808,849 |
| Soni Manmeet Singh | Chief Financial Officer | 03/11/2015 | 6,124,507 |
| Soni Manmeet Singh | Chief Financial Officer | 03/13/2015 | 870,756 |
| Zanganeh Maky | Chief Operating Officer | 03/12/2015 | 180,279 |
| Zanganeh Maky | Chief Operating Officer | 03/11/2015 | 215,700 |
| Zanganeh Maky | Chief Operating Officer | 03/11/2015 | 7,623,450 |
| Tan Heow | Chief Quality&Tech Operations | 03/12/2015 | 27,050 |
| Tan Heow | Chief Quality&Tech Operations | 03/12/2015 | 254,506 |
| Soni Manmeet Singh | Chief Financial Officer | 03/03/2015 | 560,121 |
| Tomasello Shawn | Chief Commercial Officer | 11/19/2014 | 745,798 |
| Tomasello Shawn | Chief Commercial Officer | 11/19/2014 | 745,798 |
| Fardis Maria | Chief of Oncology Ops & Allian | 11/13/2014 | 20,520 |
| Fardis Maria | Chief of Oncology Ops & Allian | 11/13/2014 | 423,903 |
| Soni Manmeet Singh | Chief Financial Officer | 11/13/2014 | 61,600 |
| Soni Manmeet Singh | Chief Financial Officer | 11/13/2014 | 141,442 |
| Zanganeh Maky | Chief Operating Officer | 11/10/2014 | 52,900 |
| Zanganeh Maky | Chief Operating Officer | 11/07/2014 | 3,567 |
| Zanganeh Maky | Chief Operating Officer | 11/12/2014 | 42,644 |
| Zanganeh Maky | Chief Operating Officer | 11/07/2014 | 209,401 |
| Zanganeh Maky | Chief Operating Officer | 11/12/2014 | 818,218 |
| Zanganeh Maky | Chief Operating Officer | 11/10/2014 | 3,078,026 |
| Love Richard B | General Counsel | 11/10/2014 | 48,570 |
| Love Richard B | General Counsel | 11/10/2014 | 200,805 |
| Fardis Maria | Chief of Oncology Ops & Allian | 11/07/2014 | 34,200 |
| Fardis Maria | Chief of Oncology Ops & Allian | 11/07/2014 | 672,500 |
| Fardis Maria | Chief of Oncology Ops & Allian | 10/31/2014 | 81 |
| Tan Heow | Chief Quality&Tech Operations | 10/31/2014 | 81 |
| Zanganeh Maky | Chief Operating Officer | 10/31/2014 | 81 |
| Soni Manmeet Singh | Chief Financial Officer | 10/31/2014 | 81 |
| Love Richard B | General Counsel | 10/31/2014 | 81 |
| Zanganeh Maky | Chief Operating Officer | 09/03/2014 | 16,100 |
| Zanganeh Maky | Chief Operating Officer | 09/04/2014 | 11,500 |
| Zanganeh Maky | Chief Operating Officer | 09/04/2014 | 610,000 |
| Zanganeh Maky | Chief Operating Officer | 09/03/2014 | 850,980 |
| Love Richard B | General Counsel | 08/27/2014 | 48,570 |
| Love Richard B | General Counsel | 08/27/2014 | 186,000 |
| Tan Heow | Chief Quality&Tech Operations | 08/21/2014 | 59,402 |
| Fardis Maria | Chief of Oncology Ops & Allian | 08/13/2014 | 27,360 |
| Fardis Maria | Chief of Oncology Ops & Allian | 08/13/2014 | 484,040 |
| Tan Heow | Chief Quality&Tech Operations | 08/13/2014 | 270,500 |
| Tan Heow | Chief Quality&Tech Operations | 08/13/2014 | 1,235,810 |
| McGreivy Jesse | Chief Medical Officer | 08/07/2014 | 2,489,515 |
| McGreivy Jesse | Chief Medical Officer | 08/07/2014 | 4,118,607 |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | 05/08/2014 | 199,997 |
| Fardis Maria | Chief of Oncology Ops & Allian | 04/30/2014 | 16,400 |
| Love Richard B | General Counsel | 04/30/2014 | 16,400 |
| Tan Heow | Chief Quality&Tech Operations | 04/30/2014 | 16,400 |
| Zanganeh Maky | Chief Operating Officer | 04/30/2014 | 16,400 |
| Soni Manmeet Singh | Chief Financial Officer | 04/30/2014 | 16,400 |
| Outten Matthew | VP, Commercial Operations | 04/30/2014 | 16,400 |
| Erdtmann Rainer M | Sr. VP, IR and Admin | 04/30/2014 | 16,400 |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | 04/30/2014 | 16,400 |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | 04/30/2014 | 16,400 |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | 04/29/2014 | 133,297 |
| Fardis Maria | Chief of Oncology Ops & Allian | 03/05/2014 | 20,520 |
| Fardis Maria | Chief of Oncology Ops & Allian | 03/05/2014 | 421,503 |
| Hemmi Gregory | Sr. VP Chemical Operations | 03/05/2014 | 12,900 |
| Hemmi Gregory | Sr. VP Chemical Operations | 03/05/2014 | 2,100,030 |
| McGreivy Jesse | Chief Medical Officer | 03/05/2014 | 166,241 |
| McGreivy Jesse | Chief Medical Officer | 03/05/2014 | 916,602 |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | 03/05/2014 | 162,203 |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | 03/04/2014 | 356,597 |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | 03/05/2014 | 880,116 |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | 03/04/2014 | 1,884,329 |
| HALVORSON ERIC H | Director | 03/04/2014 | 61,332 |
| HALVORSON ERIC H | Director | 03/04/2014 | 480,282 |
| Chang Betty Y | VP, Research/Biology | 03/04/2014 | 179,238 |
| Chang Betty Y | VP, Research/Biology | 03/04/2014 | 2,414,492 |
| van den Broek Richard | Director | 02/27/2014 | 3,623,000 |
| van den Broek Richard | Director | 02/26/2014 | 3,778,170 |
| van den Broek Richard | Director | 02/25/2014 | 4,158,493 |
| Hemmi Gregory | VP Chemical Operations | 12/30/2013 | 9,750 |
| Tan Heow | Chief Quality&Tech Operations | 12/24/2013 | 40,575 |
| Smith David Duane | Director | 12/20/2013 | 1,920 |
| Tan Heow | Chief Quality&Tech Operations | 12/19/2013 | 135,250 |
| Tan Heow | Chief Quality&Tech Operations | 12/19/2013 | 504,351 |
| Hemmi Gregory | VP Chemical Operations | 12/18/2013 | 8,600 |
| Hemmi Gregory | VP Chemical Operations | 12/17/2013 | 8,600 |
| Hemmi Gregory | VP Chemical Operations | 12/18/2013 | 990,380 |
| Hemmi Gregory | VP Chemical Operations | 12/17/2013 | 1,020,000 |
| Zanganeh Maky | Chief Operating Officer | 12/16/2013 | 2,151,000 |
| Smith David Duane | Director | 12/16/2013 | 707,024 |
| Erdtmann Rainer M | Sr. VP, IR and Admin | 12/16/2013 | 20,780 |
| Erdtmann Rainer M | Sr. VP, IR and Admin | 12/13/2013 | 28,360 |
| Erdtmann Rainer M | Sr. VP, IR and Admin | 12/16/2013 | 2,459,672 |
| Erdtmann Rainer M | Sr. VP, IR and Admin | 12/13/2013 | 3,360,117 |
| Hemmi Gregory | VP Chemical Operations | 10/31/2013 | 8,108 |
| Ray Sumita | Chief Compliance Officer | 10/31/2013 | 7,259 |
| Loury David J | Executive VP, Toxicology | 10/31/2013 | 12,024 |
| Crum Michael | Vice President, U.S. Sales | 10/31/2013 | 21,194 |
| Beaupre Darrin | VP, Clin. Med. & Early Dev. | 10/31/2013 | 8,202 |
| Tan Heow | Chief Quality&Tech Operations | 10/31/2013 | 8,829 |
| Lee Dana | VP, Clinical Drug Safety | 10/31/2013 | 14,972 |
| Soni Manmeet Singh | Executive VP, Finance | 10/31/2013 | 8,411 |
| Graef Thorsten | VP, Clinical Science | 10/31/2013 | 7,470 |
| Chang Betty Y | VP, Research/Biology | 10/31/2013 | 1,098 |
| Suchet Christopher | VP Information Technology | 10/31/2013 | 21,194 |
| Faust Elizabeth | VP Medical Affairs | 10/31/2013 | 21,194 |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | 04/30/2013 | 21,210 |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | 10/31/2013 | 1,869 |
| Shearer Scott T | VP, Global Quality | 06/06/2013 | 571,125 |
| Shearer Scott T | VP, Global Quality | 06/06/2013 | 1,596,994 |
| Hemmi Gregory | VP Chemical Operations | 05/31/2013 | 135,178 |
| Hemmi Gregory | VP Chemical Operations | 05/31/2013 | 4,598,115 |
| Tan Heow | Chief of Technical Operations | 05/31/2013 | 135,250 |
| Tan Heow | Chief of Technical Operations | 05/31/2013 | 480,961 |
| Love Richard B | VP and General Counsel | 05/31/2013 | 259,040 |
| Love Richard B | VP and General Counsel | 05/31/2013 | 712,000 |
| McGreivy Jesse | VP, Clinical Science | 05/31/2013 | 548,103 |
| McGreivy Jesse | VP, Clinical Science | 05/31/2013 | 1,319,510 |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | 04/30/2013 | 19,378 |
| Zanganeh Maky | Chief Operating Officer | 04/30/2013 | 21,241 |
| Tan Heow | Chief of Technical Operations | 04/30/2013 | 12,381 |
| Soni Manmeet Singh | VP, Corporate Controller | 04/30/2013 | 12,799 |
| Loury David J | Chief Scientific Officer | 04/30/2013 | 1,731 |
| Kunkel Lori Anne | Chief Medical Officer | 04/30/2013 | 21,247 |
| Hemmi Gregory | VP Chemical Operations | 04/30/2013 | 13,133 |
| Gayko Urte | Sr. VP, Regulatory | 04/30/2013 | 21,210 |
| Fardis Maria | Chief of Oncology Ops & Allian | 04/30/2013 | 21,241 |
| Erdtmann Rainer M | Sr. VP, IR and Admin | 04/30/2013 | 21,241 |
| Clow Fong Wang | VP Biostatistics Data Mgmt | 04/30/2013 | 21,241 |
| Buggy Joseph J | VP, Research | 04/30/2013 | 21,241 |
| Buggy Joseph J | VP, Research | 02/11/2013 | 10,320 |
| Buggy Joseph J | VP, Research | 02/11/2013 | 839,666 |
| Loury David J | Chief Scientific Officer | 02/05/2013 | 55,200 |
| Loury David J | Chief Scientific Officer | 02/05/2013 | 1,411,510 |
| McGreivy Jesse | VP, Clinical Science | 01/17/2013 | 39,229 |
| Hemmi Gregory | VP Chemical Operations | 01/11/2013 | 18,471 |
| Hemmi Gregory | VP Chemical Operations | 01/11/2013 | 335,550 |
| Loury David J | Chief Scientific Officer | 01/09/2013 | 742,014 |
| Fardis Maria | EVP, Operations and Alliances | 01/08/2013 | 162,500 |
| Loury David J | Chief Scientific Officer | 01/08/2013 | 41,600 |
| Loury David J | Chief Scientific Officer | 01/08/2013 | 647,000 |
| Fardis Maria | EVP, Operations and Alliances | 01/07/2013 | 23,940 |
| Fardis Maria | EVP, Operations and Alliances | 01/07/2013 | 224,700 |
| van den Broek Richard | Director | 12/31/2012 | 419,476 |
| van den Broek Richard | Director | 12/28/2012 | 1,064,125 |
| van den Broek Richard | Director | 12/27/2012 | 692,239 |
| Hemmi Gregory | VP Chemical Operations | 12/26/2012 | 447 |
| Hemmi Gregory | VP Chemical Operations | 12/27/2012 | 77,883 |
| Hemmi Gregory | VP Chemical Operations | 12/27/2012 | 763,725 |
| Hemmi Gregory | VP Chemical Operations | 12/26/2012 | 5,900 |
| Loury David J | Chief Scientific Officer | 12/20/2012 | 164,191 |
| Loury David J | Chief Scientific Officer | 12/20/2012 | 2,412,274 |
| Erdtmann Rainer M | VP, IR Education Training | 12/18/2012 | 54,198 |
| Erdtmann Rainer M | VP, IR Education Training | 12/17/2012 | 31,342 |
| Erdtmann Rainer M | VP, IR Education Training | 12/18/2012 | 3,721,092 |
| Erdtmann Rainer M | VP, IR Education Training | 12/17/2012 | 2,160,698 |
| Buggy Joseph J | VP, Research | 12/17/2012 | 37,500 |
| Buggy Joseph J | VP, Research | 12/17/2012 | 3,106,840 |
| Hemmi Gregory | VP Chemical Operations | 10/31/2012 | 7,242 |
| Hemmi Gregory | VP Chemical Operations | 05/08/2012 | 7,969 |
| Huh Christine | VP, Human Resources | 10/31/2012 | 21,247 |
| McGreivy Jesse | VP, Clinical Science | 10/31/2012 | 13,449 |
| Sjovall Boultbee Paula S | EVP, Sales and Marketing | 10/31/2012 | 18,870 |
| Fardis Maria | EVP, Operations and Alliances | 10/31/2012 | 3,452 |
| Loury David J | Chief Scientific Officer | 10/31/2012 | 1,721 |
| Kunkel Lori Anne | Chief Medical Officer | 10/31/2012 | 21,247 |
| Erdtmann Rainer M | VP, IR Education Training | 10/31/2012 | 15,170 |
| Buggy Joseph J | VP, Research | 10/31/2012 | 6,176 |
| Mehta Minesh | Director | 05/17/2012 | 137,259 |
| Mehta Minesh | Director | 05/17/2012 | 556,950 |
| Zanganeh Maky | Chief Business Officer | 04/30/2012 | 21,241 |
| Loury David J | Chief Scientific Officer | 04/30/2012 | 1,710 |
| Hemmi Gregory | VP Chemical Operations | 04/30/2012 | 4,803 |
| Erdtmann Rainer M | VP of Finance | 04/30/2012 | 6,070 |
| Buggy Joseph J | VP, Research | 04/30/2012 | 1,225 |
| Asbury Mark | VP and General Counsel | 04/30/2012 | 15,065 |
| Mehta Minesh | Director | 02/13/2012 | 30,148 |
| Mehta Minesh | Director | 02/13/2012 | 299,275 |
| Baker Biotech Capital (GP), LLC | 10% Owner | 02/10/2012 | 3,128,040 |
| Mehta Minesh | Director | 02/03/2012 | 30,146 |
| Mehta Minesh | Director | 02/03/2012 | 239,400 |
| Baker Biotech Capital (GP), LLC | 10% Owner | 01/25/2012 | 399,626 |
| Baker Biotech Capital (GP), LLC | 10% Owner | 01/24/2012 | 404,958 |
| Baker Biotech Capital (GP), LLC | 10% Owner | 01/26/2012 | 750,902 |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 01/24/2012 | 2,357,591 |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 01/26/2012 | 4,371,850 |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 01/25/2012 | 2,326,615 |
| 14159 capital (GP), LLC | 10% Owner | 01/26/2012 | 113,049 |
| 14159 capital (GP), LLC | 10% Owner | 01/25/2012 | 60,152 |
| 14159 capital (GP), LLC | 10% Owner | 01/24/2012 | 60,955 |
| 14159 capital (GP), LLC | 10% Owner | 01/20/2012 | 107,306 |
| 14159 capital (GP), LLC | 10% Owner | 01/19/2012 | 15,055 |
| 14159 capital (GP), LLC | 10% Owner | 01/23/2012 | 72,097 |
| 14159 capital (GP), LLC | 10% Owner | 01/20/2012 | 10,500 |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 01/23/2012 | 2,737,009 |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 01/20/2012 | 4,073,980 |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 01/19/2012 | 559,459 |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 01/20/2012 | 373,500 |
| Baker Biotech Capital (GP), LLC | 10% Owner | 01/23/2012 | 475,963 |
| Baker Biotech Capital (GP), LLC | 10% Owner | 01/20/2012 | 708,524 |
| Baker Biotech Capital (GP), LLC | 10% Owner | 01/19/2012 | 97,264 |
| Baker Biotech Capital (GP), LLC | 10% Owner | 01/20/2012 | 66,000 |
| Hemmi Gregory | VP Chemical Operations | 12/30/2011 | 124,131 |
| Hemmi Gregory | VP Chemical Operations | 12/30/2011 | 270,310 |
| Baker Biotech Capital (GP), LLC | 10% Owner | 12/02/2011 | 224,467 |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 12/02/2011 | 1,359,615 |
| 14159 capital (GP), LLC | 10% Owner | 12/02/2011 | 36,381 |
| 14159 capital (GP), LLC | 10% Owner | 11/28/2011 | 54,055 |
| 14159 capital (GP), LLC | 10% Owner | 11/29/2011 | 62,133 |
| Baker Biotech Capital (GP), LLC | 10% Owner | 11/30/2011 | 166,590 |
| Baker Biotech Capital (GP), LLC | 10% Owner | 11/29/2011 | 395,097 |
| Baker Biotech Capital (GP), LLC | 10% Owner | 11/28/2011 | 343,702 |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 11/30/2011 | 969,966 |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 11/29/2011 | 2,300,343 |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 11/28/2011 | 2,001,154 |
| 14159 capital (GP), LLC | 10% Owner | 11/23/2011 | 9,532 |
| 14159 capital (GP), LLC | 10% Owner | 11/22/2011 | 44,640 |
| 14159 capital (GP), LLC | 10% Owner | 11/21/2011 | 33,526 |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 11/23/2011 | 1,189,165 |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 11/22/2011 | 1,011,570 |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 11/21/2011 | 846,886 |
| Baker Biotech Capital (GP), LLC | 10% Owner | 11/23/2011 | 40,079 |
| Baker Biotech Capital (GP), LLC | 10% Owner | 11/22/2011 | 35,538 |
| Baker Biotech Capital (GP), LLC | 10% Owner | 11/21/2011 | 17,258 |
| Loury David J | Chief Scientific Officer | 10/31/2011 | 5,184 |
| Hemmi Gregory | VP Chemical Operations | 10/31/2011 | 4,654 |
| Hedrick Eric | Vice President | 10/31/2011 | 6,847 |
| Erdtmann Rainer M | VP of Finance | 10/31/2011 | 5,184 |
| Baker Biotech Capital (GP), LLC | 10% Owner | 09/30/2011 | 308,420 |
| Baker Biotech Capital (GP), LLC | 10% Owner | 10/03/2011 | 985,513 |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 10/03/2011 | 949,454 |
| 14159 capital (GP), LLC | 10% Owner | 10/03/2011 | 36,058 |
| 14159 capital (GP), LLC | 10% Owner | 08/22/2011 | 44,085 |
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 08/22/2011 | 2,861,270 |
| Baker Biotech Capital (GP), LLC | 10% Owner | 08/22/2011 | 395,528 |
| Hemmi Gregory | VP Chemical Operations | 07/13/2011 | 4,500 |
| DUGGAN ROBERT W | Chairman & CEO | 06/21/2011 | 6,000,300 |
| Hemmi Gregory | VP Chemical Operations | 04/29/2011 | 2,101 |
| Hamdy Ahmed MD | Chief Medical Officer | 04/29/2011 | 8,050 |
| Hedrick Eric | Vice President | 04/29/2011 | 14,399 |
| Loury David J | Chief Scientific Officer | 04/29/2011 | 16,065 |
| Erdtmann Rainer M | VP of Finance | 04/29/2011 | 16,065 |
| Zanganeh Maky | Chief of Staff & VP Bus. Dev. | 04/28/2011 | 15,000 |
| Erdtmann Rainer M | VP of Finance | 10/29/2010 | 16,065 |
| Loury David J | Chief Scientific Officer | 10/29/2010 | 16,065 |
| Hamdy Ahmed MD | Chief Medical Officer | 10/05/2010 | 10,950 |
| Hamdy Ahmed MD | Chief Medical Officer | 10/05/2010 | 123,000 |
| Buggy Joseph J | VP, Research | 10/01/2010 | 65,512 |
| Buggy Joseph J | VP, Research | 10/01/2010 | 373,669 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...